Category: Life Sciences
Global Life Sciences
-
Pre-Owned Medical Devices
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pre-Owned CT Machines, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$3.6 Billion ... Read More
-
Biochemical Reagents
... at a CAGR of 8.7% over the analysis period 2023-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$6.3 Billion by the end ... Read More
-
Bio-MEMS
... of 16.8% over the analysis period 2023-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$27.4 Billion by the end of the analysis period. ... Read More
-
Biopharmaceutical Logistics
... at a CAGR of 4.8% over the analysis period 2023-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$37.9 Billion by the end ... Read More
-
Biopharmaceutical Fermentation Systems
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Upstream Products, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.5 Billion by ... Read More
-
Brain Computer Interface
... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More
-
Extracorporeal CO2 Removal Devices
... reach US$151.9 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and ... Read More
-
Genomics and Proteomics Reagents, Research Kits and Analytical Instruments
... Kits and Analytical Instruments estimated at US$79.0 Billion in the year 2023, is expected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Biochips & Microarrays, one ... Read More
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Venturi Masks
... at a CAGR of 11.5% over the analysis period 2023-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Vancomycin
... of 4.9% over the analysis period 2023-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis ... Read More
-
Surgical Cameras
... at a CAGR of 9.0% over the analysis period 2023-2030. HD & Full HD Resolution Cameras, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$4.3 Billion ... Read More
-
Allografts
... of 6.8% over the analysis period 2023-2030. Demineralized Bone Matrix (DBM), one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$488.4 Million by the end of the ... Read More
-
Insulin Pens
... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Urinary Drainage Bags
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Leg Bags, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.8 Billion by ... Read More
-
Antibody Production
... at a CAGR of 10.5% over the analysis period 2023-2030. Monoclonal Antibody, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$27.4 Billion by the end of ... Read More
-
Flow Imaging Microscopy/Dynamic Image Analysis
... is expected to reach US$70.8 Million by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Biologics Sample, one of the segments analyzed in the report, is expected to record a 8.1% ... Read More
-
Minimally Invasive Surgery
... by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Surgical Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$70.4 Billion by ... Read More
-
Nail Care
... at a CAGR of 2.5% over the analysis period 2023-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.3 Billion by the end of ... Read More
-
Process Spectroscopy
... at a CAGR of 6.6% over the analysis period 2023-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$26.2 Billion by the end of ... Read More
-
Hospital Asset Management
... by 2030, growing at a CAGR of 11.5% over the analysis period 2023-2030. Real time Location Systems (RTLS), one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach ... Read More
-
Patient Positioning Systems
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Tables, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.2 Billion by the ... Read More
-
Fucoxanthin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... million by 2030 with a CAGR of 4.77% during the forecast period 2024-2030. North American market for Fucoxanthin was valued at $ 13.54 million in 2023 and will reach $ 19.34 million by 2030, at ... Read More
-
Veterinary Rapid Testing
... by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Testing Kits, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$1.1 Billion by ... Read More
-
Ileostomy
... of 7.5% over the analysis period 2023-2030. End Ileostomy Procedure, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
Research Assistance
